**Core tip:** Congenital perimembranous ventricular septal aneurysm is reported to be rare and its co-occurrence with severe calcific aortic stenosis is even rarest. This unique case establishes that the transcatheter aortic valve replacement can be done in patients with aneurysmal perimembranous interventricular septum. This was achieved in our case by implanting the prosthetic valve more distally into the left ventricular outflow tract requiring apposition of the Edwards SAPIEN XT skirt at annulus with most of the valvular metallic frame in supra-annular position.

INTRODUCTION
============

Extension of aneurysm in the left ventricular outflow tract (LVOT) from the perimembranous interventricular septum is a unique challenge with transcatheter aortic valve implantation (TAVR). The valve position in TAVR across the aortic annulus needs to be adequate for the proper deployment of the prosthetic valve. Presence of subvalvular aneurysm poses a challenge in effective valve deployment since there is always a possibility of serious negative outcome. The sub-annular, annular and supra-annular assessment of the landing zone is usually done using multi-imaging modality including transesophageal echocardiography (TEE) and multi-detector computer tomography (MDCT) .We describe a patient with perimembranous interventricular septum aneurysm extending into the LVOT requiring apposition of the Edwards SAPIEN XT skirt at annulus with most of the valvular metallic frame in supra-annular position.

CASE REPORT
===========

An 81-year-old male patient with post coronary artery bypass graft (CABG), pacemaker for 2:1 AV block and moderate chronic obstructive lung disease (COPD), history of TIA was planned for the TAVR for symptomatic severe aortic stenosis in view of high risk for open aortic valve replacement (Society of Thoracic Surgeons score of 8-12). He presented with recent worsening of shortness of breath. The high STS score in this patient was determined based on multiple factors which are part of the scoring criteria including presence of aortic insufficiency, previous CAD, Moderate COPD per PFT results, prior sternotomy/CABG. TEE showed a perimembranous ventricular septal aneurysm with LVOT extension and severe calcific stenotic aortic valve (AVA of 0.9 cm^2^) with moderate aortic regurgitation (Figure [1A](#F1){ref-type="fig"}). Pre-procedural CT findings confirmed the focal septal aneurysm below the aortic annulus in the transverse section (Figure [1B](#F1){ref-type="fig"}) and in the coronal section (Figure [1C](#F1){ref-type="fig"}). The aneurysm extended from 0.2 mm below the annulus to 14.5 mm along the septum on 3-D reconstructed CT image (Figure [1D](#F1){ref-type="fig"}). Distances from the aortic annulus to left main and right coronary ostium were 12.9 mm and 18.9 mm respectively (Figure [1E](#F1){ref-type="fig"} and F). The aortic annular measurements included: maximum and minimum diameter in the cross-sectional view of 29 mm and 25.5 mm respectively (average diameter of 27.3 mm); perimeter of 87.2 mm and annular area of 594.3 mm^2^. Figure [2A](#F2){ref-type="fig"} and B demonstrate the sub-annular area of 571.8 mm^2^ at the level of aneurysm in membranous septum. The aortic annular cross-sectional area on multi-planar reformatted en-face view was 602 mm^2^ (40% phase), suggesting a 29 mm Edwards SAPIEN XT valve.

![Assessment of the calcific aortic valve and interventricular septal aneurysm prior to transcatheter aortic valve replacement. A: Transesophageal echocardiography shows a perimembranous ventricular septal aneurysm (arrow) and severe calcific stenotic aortic valve with moderate aortic regurgitation; B: Cardiac computer tomography (CT) findings confirmed the focal interventricular septal aneurysm (arrow) below the aortic annulus in the transverse view along the membranous septum with left ventricular outflow tract extension (arrowhead); C: Cardiac CT in coronal view showing interventricular septal aneurysm (arrow) below the annulus; D: The dimension at the neck of septal aneurysm (arrow) was 14.5 mm on 3-D reconstructed CT image; E and F: The aortic annulus to left main ostium distance was 12.9 mm and annulus to right coronary ostium distance was 18.9 mm.](WJC-10-1-g001){#F1}

![Measurements below and at the level of aortic annulus. A: The aortic measurements included area of 571.8 mm\[[@B2]\]; B: Perimeter of 85 mm at 0.2 mm below the level of annulus, and also at 4.1 mm below the annulus and at level of aneurysm.](WJC-10-1-g002){#F2}

A 29 mm balloon-expandable transcatheter valve was positioned across the aortic annulus using the NovaFlex delivery system (Edwards Lifesciences, Irvine, CA, United States) after appropriate valve orientation by transfemoral approach. The Edwards SAPIEN XT prosthetic valve comes with the total frame height of 19.1 mm and skirt height of 12 mm. The valve was positioned at supra-annular position with 80% aortic and 20% ventricular ratio at the level of leaflet insertion of the native valve, given the presence of septal aneurysm with LVOT extension (Figure [3A](#F3){ref-type="fig"}). Appropriate valve deployment was achieved. No paravalvular aortic regurgitation with patent coronaries was noticed post-valve deployment (Figure [3B](#F3){ref-type="fig"}). The patient tolerated the procedure well and was discharged two days after procedure. At 8 week follow-up, patient had improved symptoms with repeat Cardiac CT scan showing stable prosthetic valve and no change in the perimembranous aneurysm (Figure [3C](#F3){ref-type="fig"}).

![Post deployment assessment of the 29 mm Edwards SAPIEN XT valve at aortic position. A: Deployment of the 29 mm Edwards SAPIEN XT valve at the level of tip of pig tail catheter; B: Immediately after deployment of 29 mm Edwards SAPIEN XT valve, TEE shows color doppler signals in interventricular septal aneurysm (arrows); C: Follow up cardiac computer tomography showed stable prosthetic valve and interventricular septal aneurysm (arrow).](WJC-10-1-g003){#F3}

DISCUSSION
==========

Congenital perimembranous ventricular septal aneurysms are not uncommon. Incidence of interventricular membranous septum aneurysm is reported to occur in 0.3 % of patients with congenital heart disease\[[@B1]\]. Etiology includes idiopathic or may be related to healed ventricular septal defect\[[@B1],[@B2]\]. But there are few reports that relate the development to a previous episode of infection or trauma\[[@B3]\]. These aneurysms can be classified as true, false and pseudo-aneurysm\[[@B4]\]. Those with a wide base and regular contours are true while those with a narrow base and irregular shape are termed as false. A pseudo-aneurysm is complication of ischemic insults or transaortic septal myotomy\[[@B4]\]. Patients with interventricular septum aneurysm are often asymptomatic; if symptoms develop they are usually related to an associated complication. Like other aneurysms this anomaly predisposes patients to arrhythmogenic and thrombogenic events. Different modalities including conventional ventriculography, echocardiogram, cardiac MRI and MDCT are used for diagnosis. Morphological and functional assessment can be done with cardiac MRI or MDCT\[[@B4]\]. Both cardiac MRI and MDCT can also be used after surgery to determine the integrity of the patch and also to identify any residual defect but CT gives radiation exposure\[[@B4]\] .

Surgical intervention is rarely indicated except when concurrent heart diseases, hemodynamic abnormalities, and aneurysm-related complications are detected. Presence of thrombus may justify anticoagulation treatment\[[@B5]\]. Failure of anticoagulation therapy is an indication for surgical resection even in the absence of echocardiographic evidence of thrombus\[[@B5]\]. So periodic echocardiographic examination is recommended by some clinicians. Direct surgical ablation has shown satisfactory outcomes in patients with life threatening ventricular arrhythmias. Failure to precisely localize conduction system at the operation can lead to the development of complete heart block\[[@B6]\]. Although surgical option is available, most of them are left as such if they do not complicate. In our patient there was never a need to address it in the past. But as the patient was undergoing TAVR, the interventricular septum was assessed using imaging modalities.

Cardiac MDCT may be the optimal imaging modality to characterize not only the size and location of septal aneurysm\[[@B7],[@B8]\], but also for pre-procedural TAVR planning. Proper assessment of the landing zone including the sub-valvular area below the aortic annulus and along the LVOT is essential. It has been seen that most favorable results are obtained during deployment when full coverage of the aortic leaflets is obtained with secure anchoring at and below the level of the insertion of the native valve leaflets. Based on these observations, the conventional recommendation is to implant the device with 50% above and 50% below native leaflet insertion\[[@B9]\]. But multiple positions have been documented in the literature showing variable ventricular device fractions below the anatomical annulus ranging from low to high\[[@B9]\]. Deployment of the Edwards SAPIEN XT prosthetic valve either getting positioned in a more sub-annular or more supra-annular location is quiet common. Most of the deployments are more supra-annular with varying aortic to ventricular ratio from 60:40 to 90:10.

The real-time imaging in the catheterization lab is inadequate for judgement of the level of leaflet insertion of the native valves. Therefore, the virtual basal ring, which is the anatomical annulus, is taken as the line of implantation during deployment. Malposition of valve can result in valve migration and resulting more severe para-valvular leak or embolization in high supra-annular placement *vs* more chances of AV conduction blocks in sub-annular placement\[[@B10]\]. Other complications including post TAVR shunts have also been reported\[[@B11]\]. Careful placement of the prosthetic valve in a more aortic position like in our case can be the solution despite the presence of aneurysm at the sub-aortic level. This placement does not affect the outcome provided the balloon-expandable valve is strategically placed more aortic than usual position, allowing the transcatheter valve skirt to completely cover the annulus reducing chances of paravalvular leak, as seen in our patient. Now Edward SAPIEN 3 is available which is a new fourth generation valve in the balloon-expandable Sapien series of devices and is easy to deploy due to its ultra-low delivery profile. At that time, the operators had good experience with Edward SAPIEN XT, and the new generation valve was under research. As per our knowledge, the present case is the first report of the utilization of TAVR procedure in a patient with interventricular septal aneurysm and need of higher aortic positioning with an Edward SAPIEN XT valve.

This case emphasizes the feasibility of doing TAVR in patients with interventricular septal aneurysm with LVOT extension. The present case also demonstrates the advantage of careful planning and strategic deployment of the TAVR prosthetic valve in patients with the above anomaly.

ARTICLE HIGHLIGHTS
==================

Case characteristics
--------------------

Patient with severe calcific aortic stenosis presented with worsening symptom of shortness of breath.

Clinical diagnosis
------------------

Patient was diagnosed as symptomatic severe aortic stenosis clinically.

Differential diagnosis
----------------------

Left ventricular outflow tract obstruction, sub-valvular aortic stenosis and supra-valvular aortic stenosis are the differentials.

Laboratory diagnosis
--------------------

ECG showed intermittent paced rhythm due to pacemaker and chest x-ray showed sternal wires due to previous coronary artery bypass graft.

Imaging diagnosis
-----------------

Echocardiography and computer tomography showed severe calcific aortic stenosis with perimembranous interventricular septum aneurysm extending into left ventricular outflow tract.

Pathological diagnosis
----------------------

Patient had congenital heart defect which included interventricular septum aneurysm extending into left ventricular outflow tract with acquired severe calcific stenosis of tri-leaflet aortic valve.

Treatment
---------

The patient was treated with transcatheter aortic valve replacement .This was achieved in our case by implanting the prosthetic valve more distally into the left ventricular outflow tract (LVOT) requiring apposition of the Edwards SAPIEN XT skirt at annulus with most of the valvular metallic frame in supra-annular position.

Related reports
---------------

During transcatheter aortic valve replacement, normally the conventional recommendation is to implant the device with 50% above and 50% below native leaflet insertion .We had 80% aortic and 20% ventricular ratio of the device at the level of leaflet insertion of the native valve.

Term explanation
----------------

LVOT denotes left ventricular outflow tract obstruction and TAVR denotes transcatheter aortic valve replacement.

Experiences and lessons
-----------------------

The transcatheter aortic valve replacement can be done in patients having high surgical risk with perimembranous interventricuar septum aneurysm by implanting the device more distally into the LVOT.
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